Burning Rock Biotech (BNR) Long-Term Investments (2021 - 2023)

Burning Rock Biotech has reported Long-Term Investments over the past 3 years, most recently at $46805.1 for Q4 2023.

  • Quarterly results put Long-Term Investments at $46805.1 for Q4 2023, down 51.76% from a year ago — trailing twelve months through Dec 2023 was $46805.1 (down 51.76% YoY), and the annual figure for FY2023 was $47000.0, down 54.27%.
  • Long-Term Investments for Q4 2023 was $46805.1 at Burning Rock Biotech, down from $97016.8 in the prior quarter.
  • Over the last five years, Long-Term Investments for BNR hit a ceiling of $142332.7 in Q4 2021 and a floor of $46805.1 in Q4 2023.
  • Median Long-Term Investments over the past 3 years was $97016.8 (2022), compared with a mean of $95384.9.
  • Biggest five-year swings in Long-Term Investments: crashed 31.84% in 2022 and later tumbled 51.76% in 2023.
  • Burning Rock Biotech's Long-Term Investments stood at $142332.7 in 2021, then crashed by 31.84% to $97016.8 in 2022, then tumbled by 51.76% to $46805.1 in 2023.
  • The last three reported values for Long-Term Investments were $46805.1 (Q4 2023), $97016.8 (Q4 2022), and $142332.7 (Q4 2021) per Business Quant data.